Group B Strep Support Revenue and Competitors

We're a UK-based charity, formed in 1996, and supported by a highly respected medical advisory panel. Our goal remains unchanged – to stop group B Strep infection in babies. In the UK: - Two babies a day develop group B Strep infection - One baby a week dies from group B Strep infection - One baby a week survives their group B Strep infection with disability The charity's three main aims are to: - Offer information and support to families affected by group B Streptococcus; - Inform health professionals and individuals how most group B Strep infections in newborn babies can be prevented; and - Generate continued support for research into preventing group B Strep infections in newborn babies. Every woman should be informed about group B Strep and offered a sensitive (ECM) test to detect GBS carriage late in pregnancy. The results of these tests can then be used to inform as to what further treatment may be needed, if any, to minimise the risk of GBS infection in the newborn baby. ECM tests are not yet widely available within the NHS, although they are available privately (and cost approximately £35-£40). An antenatal screening programme for Strep B would prevent most of these infections in newborns and, longer term, a vaccine could prevent more cases of GBS infection than any other strategy, including stillbirths caused by GBS, post-delivery GBS infection in the mother and late-onset GBS infection in the baby. Investment into developing a vaccine against GBS infection is urgently needed.